These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 6527968)

  • 21. [Variations in the urinary level of MHPG in depressive syndromes].
    Loeb C; Roccatagliatà G; Besio G
    Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):337-48. PubMed ID: 555549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-MHPG as a non-predictor of antidepressant response to imipramine and electroconvulsive therapy.
    Sharma IJ; Venkitasubramanian TA; Agnihotri BR
    Acta Psychiatr Scand; 1986 Sep; 74(3):252-4. PubMed ID: 3788651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline.
    Beckmann H; Goodwin FK
    Arch Gen Psychiatry; 1975 Jan; 32(1):17-21. PubMed ID: 1089399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does 24-h urinary MHPG predict treatment response to antidepressants? II. Association between imipramine response and low MHPG.
    Garvey M; DeRubeis RJ; Hollon SD; Evans MD; Tuason VB
    J Affect Disord; 1990 Nov; 20(3):181-4. PubMed ID: 2148338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary MHPG and response to amitriptyline.
    Modai I; Apter A; Golomb M; Wijsenbeek H
    Arch Gen Psychiatry; 1983 Apr; 40(4):467. PubMed ID: 6838327
    [No Abstract]   [Full Text] [Related]  

  • 27. Urinary amine metabolites in depression: a combined biochemical and general practice study: II. Biochemical aspects.
    Ridges AP; Bishop FM; Goldberg IJ
    J Int Med Res; 1980; 8 Suppl 3():37-44. PubMed ID: 6162689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does 24-h urinary MHPG predict treatment response to antidepressants? I. A review.
    Garvey M; Hollon SD; DeRubeis RJ; Evans MD; Tuason VB
    J Affect Disord; 1990 Nov; 20(3):173-9. PubMed ID: 2148337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical, pharmacologic and psychophysiologic studies for the optimization of drug therapy in depressive illnesses].
    Gaertner HJ; Giedke H; Breyer-Pfaff U
    Nervenarzt; 1984 Mar; 55(3):133-6. PubMed ID: 6717696
    [No Abstract]   [Full Text] [Related]  

  • 30. Noradrenergic output and clinical response in depressed women during amitriptyline therapy.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Pharmacopsychiatry; 1989 Jul; 22(4):144-51. PubMed ID: 2762377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam.
    Mooney JJ; Cole JO; Schatzberg AF; Gerson B; Schildkraut JJ
    Am J Psychiatry; 1985 Mar; 142(3):366-7. PubMed ID: 2857533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do urinary MHPG and plasma drug levels correlate with response to amitriptyline therapy?
    Gaertner HJ; Kreuter F; Scharek G; Wiatr G; Breyer-Pfaff U
    Psychopharmacology (Berl); 1982; 76(3):236-9. PubMed ID: 6808543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy issues with antidepressants.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1997; 58 Suppl 6():32-9. PubMed ID: 9227671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of Hydiphen in the treatment of endogenous depression].
    Nowakowska C; Chłopocka-Woźniak M; Strzyzewski W
    Psychiatr Pol; 1989; 23(1):10-7. PubMed ID: 2682710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tryptophan and tyrosine availability: relation to clinical response to antidepressive pharmacotherapy.
    Møller SE; Larsen OB
    Adv Biochem Psychopharmacol; 1984; 39():319-26. PubMed ID: 6380228
    [No Abstract]   [Full Text] [Related]  

  • 36. [Different urinary excretion of 3-methoxy-4-hydroxyphenyl-glycol and response to tricyclic antidepressive drugs].
    Beckmann H; Jones C; Goodwin FK
    Arzneimittelforschung; 1974 Jul; 24(7):1010-2. PubMed ID: 4408047
    [No Abstract]   [Full Text] [Related]  

  • 37. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 38. Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions.
    Rosenbaum AH; Maruta T; Schatzberg AF; Orsulak PJ; Jiang NS; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1983 Mar; 140(3):314-8. PubMed ID: 6829802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings].
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Cole JO; Rosenbaum AH
    Psychopharmacol Bull; 1981 Jan; 17(1):90-91. PubMed ID: 7232668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.